Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement from the American Heart Association

Seema Mital, Kiran Musunuru, Vidu Garg, Mark W. Russell, David E. Lanfear, Rajat M. Gupta, Kathleen T. Hickey, Michael J. Ackerman, Marco V. Perez, Dan M. Roden, Daniel Woo, Caroline S. Fox, Stephanie Ware

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Advances in genomics are enhancing our understanding of the genetic basis of cardiovascular diseases, both congenital and acquired, and stroke. These advances include finding genes that cause or increase the risk for childhood and adult-onset diseases, finding genes that influence how patients respond to medications, and the development of genetics-guided therapies for diseases. However, the ability of cardiovascular and stroke clinicians to fully understand and apply this knowledge to the care of their patients has lagged. This statement addresses what the specialist caring for patients with cardiovascular diseases and stroke should know about genetics; how they can gain this knowledge; how they can keep up-to-date with advances in genetics, genomics, and pharmacogenetics; and how they can apply this knowledge to improve the care of patients and families with cardiovascular diseases and stroke.

Original languageEnglish (US)
Pages (from-to)448-467
Number of pages20
JournalCirculation: Cardiovascular Genetics
Volume9
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Cardiovascular Diseases
Myocardial Infarction
Genomics
Patient Care
Aptitude
Pharmacogenetics
Genetic Therapy
Genes
Stroke
Literacy

Keywords

  • AHA Scientific Statements
  • aneurysm
  • arrhythmia
  • cardiomyopathy
  • channelopathy
  • congenital heart defects
  • genetic testing
  • genetics
  • pharmacogenetics
  • pharmacology

ASJC Scopus subject areas

  • Genetics
  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)

Cite this

Enhancing Literacy in Cardiovascular Genetics : A Scientific Statement from the American Heart Association. / Mital, Seema; Musunuru, Kiran; Garg, Vidu; Russell, Mark W.; Lanfear, David E.; Gupta, Rajat M.; Hickey, Kathleen T.; Ackerman, Michael J.; Perez, Marco V.; Roden, Dan M.; Woo, Daniel; Fox, Caroline S.; Ware, Stephanie.

In: Circulation: Cardiovascular Genetics, Vol. 9, No. 5, 01.10.2016, p. 448-467.

Research output: Contribution to journalArticle

Mital, S, Musunuru, K, Garg, V, Russell, MW, Lanfear, DE, Gupta, RM, Hickey, KT, Ackerman, MJ, Perez, MV, Roden, DM, Woo, D, Fox, CS & Ware, S 2016, 'Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement from the American Heart Association', Circulation: Cardiovascular Genetics, vol. 9, no. 5, pp. 448-467. https://doi.org/10.1161/HCG.0000000000000031
Mital, Seema ; Musunuru, Kiran ; Garg, Vidu ; Russell, Mark W. ; Lanfear, David E. ; Gupta, Rajat M. ; Hickey, Kathleen T. ; Ackerman, Michael J. ; Perez, Marco V. ; Roden, Dan M. ; Woo, Daniel ; Fox, Caroline S. ; Ware, Stephanie. / Enhancing Literacy in Cardiovascular Genetics : A Scientific Statement from the American Heart Association. In: Circulation: Cardiovascular Genetics. 2016 ; Vol. 9, No. 5. pp. 448-467.
@article{2ca8372f1d3b43f8b72e12cc53bba2b5,
title = "Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement from the American Heart Association",
abstract = "Advances in genomics are enhancing our understanding of the genetic basis of cardiovascular diseases, both congenital and acquired, and stroke. These advances include finding genes that cause or increase the risk for childhood and adult-onset diseases, finding genes that influence how patients respond to medications, and the development of genetics-guided therapies for diseases. However, the ability of cardiovascular and stroke clinicians to fully understand and apply this knowledge to the care of their patients has lagged. This statement addresses what the specialist caring for patients with cardiovascular diseases and stroke should know about genetics; how they can gain this knowledge; how they can keep up-to-date with advances in genetics, genomics, and pharmacogenetics; and how they can apply this knowledge to improve the care of patients and families with cardiovascular diseases and stroke.",
keywords = "AHA Scientific Statements, aneurysm, arrhythmia, cardiomyopathy, channelopathy, congenital heart defects, genetic testing, genetics, pharmacogenetics, pharmacology",
author = "Seema Mital and Kiran Musunuru and Vidu Garg and Russell, {Mark W.} and Lanfear, {David E.} and Gupta, {Rajat M.} and Hickey, {Kathleen T.} and Ackerman, {Michael J.} and Perez, {Marco V.} and Roden, {Dan M.} and Daniel Woo and Fox, {Caroline S.} and Stephanie Ware",
year = "2016",
month = "10",
day = "1",
doi = "10.1161/HCG.0000000000000031",
language = "English (US)",
volume = "9",
pages = "448--467",
journal = "Circulation. Genomic and precision medicine",
issn = "1942-325X",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "5",

}

TY - JOUR

T1 - Enhancing Literacy in Cardiovascular Genetics

T2 - A Scientific Statement from the American Heart Association

AU - Mital, Seema

AU - Musunuru, Kiran

AU - Garg, Vidu

AU - Russell, Mark W.

AU - Lanfear, David E.

AU - Gupta, Rajat M.

AU - Hickey, Kathleen T.

AU - Ackerman, Michael J.

AU - Perez, Marco V.

AU - Roden, Dan M.

AU - Woo, Daniel

AU - Fox, Caroline S.

AU - Ware, Stephanie

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Advances in genomics are enhancing our understanding of the genetic basis of cardiovascular diseases, both congenital and acquired, and stroke. These advances include finding genes that cause or increase the risk for childhood and adult-onset diseases, finding genes that influence how patients respond to medications, and the development of genetics-guided therapies for diseases. However, the ability of cardiovascular and stroke clinicians to fully understand and apply this knowledge to the care of their patients has lagged. This statement addresses what the specialist caring for patients with cardiovascular diseases and stroke should know about genetics; how they can gain this knowledge; how they can keep up-to-date with advances in genetics, genomics, and pharmacogenetics; and how they can apply this knowledge to improve the care of patients and families with cardiovascular diseases and stroke.

AB - Advances in genomics are enhancing our understanding of the genetic basis of cardiovascular diseases, both congenital and acquired, and stroke. These advances include finding genes that cause or increase the risk for childhood and adult-onset diseases, finding genes that influence how patients respond to medications, and the development of genetics-guided therapies for diseases. However, the ability of cardiovascular and stroke clinicians to fully understand and apply this knowledge to the care of their patients has lagged. This statement addresses what the specialist caring for patients with cardiovascular diseases and stroke should know about genetics; how they can gain this knowledge; how they can keep up-to-date with advances in genetics, genomics, and pharmacogenetics; and how they can apply this knowledge to improve the care of patients and families with cardiovascular diseases and stroke.

KW - AHA Scientific Statements

KW - aneurysm

KW - arrhythmia

KW - cardiomyopathy

KW - channelopathy

KW - congenital heart defects

KW - genetic testing

KW - genetics

KW - pharmacogenetics

KW - pharmacology

UR - http://www.scopus.com/inward/record.url?scp=84992437572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992437572&partnerID=8YFLogxK

U2 - 10.1161/HCG.0000000000000031

DO - 10.1161/HCG.0000000000000031

M3 - Article

C2 - 27672144

AN - SCOPUS:84992437572

VL - 9

SP - 448

EP - 467

JO - Circulation. Genomic and precision medicine

JF - Circulation. Genomic and precision medicine

SN - 1942-325X

IS - 5

ER -